Belharra Therapeutics

Belharra Therapeutics is an early-stage small molecule discovery company founded by pioneers in the field of chemical biology. Through the application of our proprietary chemoproteomics platform merged with innovative biology and medicinal chemistry, we are modulating protein function in previously unidentified ways to push the limits of drug discovery. Our aim is to deliver transformative, first-in-class medicines for patients suffering from the most serious diseases.